Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale Bixby

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Hematology. American Society of Hematology. Education Program|December 17, 2009
Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistanceDale Bixby, Moshe Talpaz
Leukemia & Lymphoma|January 5, 2016
Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phaseLuke P Akard, Dale Bixby
Case Reports in Oncology|May 27, 2026
High-Risk Acute Myeloid Leukemia Developing in a Patient with Recurrent Melanoma: A Case ReportMaisha Anika, Dale Bixby, Tarek Haykal
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemiaElias J Jabbour, Dale Bixby, Luke P Akard
Journal of the Endocrine Society|April 27, 2018
Fibroblast Growth Factor 23-Induced Hypophosphatemia in Acute LeukemiaRachel B Reinert, Dale Bixby, Ronald J Koenig
Cell Cycle (Georgetown, Tex.)|April 17, 2008
The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosisDale Bixby, Lisa Kujawski, Shaomeng Wang, et al.
The Journal of Molecular Diagnostics : JMD|May 11, 2016
Genome-Wide Single-Nucleotide Polymorphism Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/LymphomaYunhong Wang, Sue Miller, Diane Roulston, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2015
Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunctionJacob A Barker, Bernard L Marini, Dale Bixby, et al.
Journal of Leukemia (Los Angeles, Calif.)|July 30, 2015
The Challenge of t (6;9) and FLT3-Positive Acute Myelogenous Leukemia in a Young AdultYeohan Song, Dale Bixby, Diane Roulston, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2021
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase InhibitorsJustin Shaya, Kristen Pettit, Malathi Kandarpa, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Hematology. American Society of Hematology. Education Program|December 17, 2009
Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistanceDale Bixby, Moshe Talpaz
Leukemia & Lymphoma|January 5, 2016
Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phaseLuke P Akard, Dale Bixby
Case Reports in Oncology|May 27, 2026
High-Risk Acute Myeloid Leukemia Developing in a Patient with Recurrent Melanoma: A Case ReportMaisha Anika, Dale Bixby, Tarek Haykal
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemiaElias J Jabbour, Dale Bixby, Luke P Akard
Journal of the Endocrine Society|April 27, 2018
Fibroblast Growth Factor 23-Induced Hypophosphatemia in Acute LeukemiaRachel B Reinert, Dale Bixby, Ronald J Koenig
Cell Cycle (Georgetown, Tex.)|April 17, 2008
The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosisDale Bixby, Lisa Kujawski, Shaomeng Wang, et al.
The Journal of Molecular Diagnostics : JMD|May 11, 2016
Genome-Wide Single-Nucleotide Polymorphism Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/LymphomaYunhong Wang, Sue Miller, Diane Roulston, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2015
Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunctionJacob A Barker, Bernard L Marini, Dale Bixby, et al.
Journal of Leukemia (Los Angeles, Calif.)|July 30, 2015
The Challenge of t (6;9) and FLT3-Positive Acute Myelogenous Leukemia in a Young AdultYeohan Song, Dale Bixby, Diane Roulston, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2021
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase InhibitorsJustin Shaya, Kristen Pettit, Malathi Kandarpa, et al.
Pageof 5